“The Innovations in Wound Healing Symposium is an important venue for advancing the scientific conversation in our field,” said Dr. Roger Ilagan, Chief Scientific Officer at Merakris Therapeutics. “I ...

Founded in 2009, Tides has evolved from a distributor of birth-tissue products into a biotechnology platform focused on ...

Zevaskyn, the first gene therapy for recessive dystrophic epidermolysis bullosa, showed significant wound healing in phase 3 ...

Engineers at the University of California, Santa Cruz have developed a new smart bandage called “a-Heal” that may change how ...

FibroBiologics files a new USPTO patent covering its fibroblast-based platform for disc repair, cartilage restoration, and ...

Neurotrophic keratopathy (NK) is a rare disease of the cornea. It has no or little sensation but can progress to a deeper wound of the cornea and possibly vision loss. We found seven studies that ...

Enabling Pivotal Phase 2/3 STEP Study in Epidermolysis BullosaPress release2025-12-09 09:28Helene Hartman, CEO of XinnateLund, Sweden – Xinnate is taking a major step toward reshaping the treatment ...

The first-of-its kind gene therapy uses a patient’s skin cells to create sheets to treat the open wounds caused by the rare, ...

By day, Harold Wayne Nichols was a loving husband who was adored by his wife. By night, he was a serial predator who attacked ...

INmune Bio, Inc. (NASDAQ: INMB) ('INmune” or the 'Company”), a clinical-stage inflammation and immunology company, announces a recently published overview of future applications and research areas for ...

Aging taps us on the shoulder in many ways: wrinkles, thinning hair, loss of flexibility, slowing of the brain. But the ...

You learn what matters and what absolutely doesn’t, and you stop wasting energy on people or situations that drain you. This ...